Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00495651
What this trial is testing

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

Who this might be right for
HIV InfectionsTuberculosis
French National Agency for Research on AIDS and Viral Hepatitis 2,073
Post-approval studies (Phase 4)Study completedNCT00600366
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 71
Testing effectiveness (Phase 2)UnknownNCT00703872
What this trial is testing

HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Hepasome Pharmaceuticals 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07508995
What this trial is testing

Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00050973
What this trial is testing

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eisai Inc. 623
Early research (Phase 1)Study completedNCT01638650
What this trial is testing

Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04458272
What this trial is testing

DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II Glioma

Who this might be right for
WHO Grade II Glioma
Daiichi Sankyo Co., Ltd. 25
Post-approval studies (Phase 4)Study completedNCT00647101
What this trial is testing

Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Testing effectiveness (Phase 2)UnknownNCT06530511
What this trial is testing

Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Affiliated Hospital of Nantong University 30
Testing effectiveness (Phase 2)Study completedNCT02151695
What this trial is testing

Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

Who this might be right for
Naive Patients With Uncomplicated Proliferative Diabetic Retinopathy
Poitiers University Hospital 41
Post-approval studies (Phase 4)Study completedNCT00614471
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 219
Testing effectiveness (Phase 2)Study completedNCT00411996
What this trial is testing

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 20
Large-scale testing (Phase 3)Study completedNCT00138567
What this trial is testing

Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 530
Testing effectiveness (Phase 2)Looking for participantsNCT05570825
What this trial is testing

SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IIIC Lung Cancer AJCC v8+1 more
University of Washington 30
Not applicableStudy completedNCT02626923
What this trial is testing

Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients

Who this might be right for
Drug-induced Hypotension
Nicholaos C Bellos, MD 51
Large-scale testing (Phase 3)Study completedNCT00102388
What this trial is testing

Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 1,092
Testing effectiveness (Phase 2)Study completedNCT00002390
What this trial is testing

The Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Ended earlyNCT01716546
What this trial is testing

Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hellenic Oncology Research Group 51
Not applicableLooking for participantsNCT06760806
What this trial is testing

Evaluation of Toxicities in Patients Treated With Palliative Radiotherapy at Policlinico Sant Orsola of Bologna.

Who this might be right for
Palliative Care
IRCCS Azienda Ospedaliero-Universitaria di Bologna 7,000
Not applicableStudy completedNCT04439526
What this trial is testing

Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag S.p.A. 356
Next Page